Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor-associated myocarditis
Cau R.First
;Scartozzi M.;Montisci R.;Saba L.
2022-01-01
Abstract
Immune checkpoint inhibitor (ICI)-induced cardiotoxicity is a rare immune-related adverse event (irAE) characterized by a high mortality rate. From a pathological point of view, this condition can result from a series of causes, including binding of ICIs to target molecules on nonlymphocytic cells, cross-reaction of T lymphocytes against tumor antigens with off-target tissues, generation of autoantibodies and production of proinflammatory cytokines. The diagnosis of ICI-induced cardiotoxicity can be challenging, and cardiac magnetic resonance (CMR) represents the diagnostic tool of choice in clinically stable patients with suspected myocarditis. CMR is gaining a central role in diagnosis and monitoring of cardiovascular damage in cancer patients, and it is entering international cardiology and oncology guidelines. In this narrative review, we summarized the clinical aspects of ICI-associated myocarditis, highlighting its radiological aspects and proposing a novel algorithm for the use of CMR.File | Size | Format | |
---|---|---|---|
Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor-associated myocarditis_compressed.pdf Solo gestori archivio
Type: versione editoriale
Size 762.78 kB
Format Adobe PDF
|
762.78 kB | Adobe PDF | & nbsp; View / Open Request a copy |
Manuscript _merged.pdf open access
Type: versione pre-print
Size 686.3 kB
Format Adobe PDF
|
686.3 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.